glp-1 drug news People on drugs can lose drastic amounts of weight, including some muscle. An experimental might help people retain some of this lean mass. (📸: PixelsEffect/E+/Getty Images) #science #medicine #health #glp1 # The promises and pitfalls of

This multi-strain probiotic is formulated with beneficial bacteria that naturally increase GLP-1, the un-hunger hormone that helps curb cravings & appetite

Vegetarian capsules with chlorophyll, no artificial additives

In the last 20 years, the emergence of pharmacological treatments for obesity based on gastrointestinal hormones has transformed the ...

The glp-1 agonists market is expected to reach US$ 118,926.1 billion by 2032, growing at a significant CAGR of 18.1% from 2026 to 2032.

GLP-1s claimed the top two spots in 2024 drug spending and accounted for more than one-third of the top 10 drugs overall.

The results of the PIONEER-3 trial have now been published in the renowned journal Journal of the American Medical Association (JAMA) and are said to be trend-setting for future therapy of type 2 diabetes.